LeMaitre Vascular (NASDAQ:LMAT) Updates FY 2025 Earnings Guidance

LeMaitre Vascular (NASDAQ:LMAT - Get Free Report) updated its FY 2025 earnings guidance on Thursday. The company provided earnings per share guidance of 2.150-2.320 for the period, compared to the consensus earnings per share estimate of 2.160. The company issued revenue guidance of $235.4 million-$242.8 million, compared to the consensus revenue estimate of $240.2 million. LeMaitre Vascular also updated its Q1 2025 guidance to 0.480-0.530 EPS.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on the company. StockNews.com lowered LeMaitre Vascular from a "buy" rating to a "hold" rating in a report on Friday, December 13th. Wells Fargo & Company began coverage on LeMaitre Vascular in a research report on Thursday, February 13th. They issued an "equal weight" rating and a $95.00 price target for the company. Barrington Research lowered LeMaitre Vascular from an "outperform" rating to a "market perform" rating in a research report on Friday. Oppenheimer lowered LeMaitre Vascular from an "outperform" rating to a "market perform" rating in a research report on Friday. Finally, Lake Street Capital increased their price target on LeMaitre Vascular from $105.00 to $110.00 and gave the company a "buy" rating in a research report on Friday. Five equities research analysts have rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, LeMaitre Vascular has a consensus rating of "Moderate Buy" and an average target price of $95.25.

Remove Ads

LeMaitre Vascular Trading Up 0.3 %

NASDAQ LMAT traded up $0.31 during trading on Monday, reaching $92.16. 299,488 shares of the company's stock were exchanged, compared to its average volume of 137,430. LeMaitre Vascular has a fifty-two week low of $62.39 and a fifty-two week high of $109.58. The firm has a market capitalization of $2.07 billion, a PE ratio of 50.36, a P/E/G ratio of 2.22 and a beta of 0.96. The company's fifty day simple moving average is $96.89 and its 200-day simple moving average is $94.90.

LeMaitre Vascular (NASDAQ:LMAT - Get Free Report) last announced its quarterly earnings data on Thursday, February 27th. The medical instruments supplier reported $0.49 EPS for the quarter, hitting analysts' consensus estimates of $0.49. LeMaitre Vascular had a return on equity of 13.15% and a net margin of 19.40%. The firm had revenue of $55.81 million during the quarter, compared to analyst estimates of $55.99 million. Equities analysts forecast that LeMaitre Vascular will post 1.94 EPS for the current fiscal year.

LeMaitre Vascular Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, March 27th. Stockholders of record on Thursday, March 13th will be issued a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a dividend yield of 0.87%. This is a positive change from LeMaitre Vascular's previous quarterly dividend of $0.16. The ex-dividend date of this dividend is Thursday, March 13th. LeMaitre Vascular's payout ratio is currently 41.24%.

LeMaitre Vascular Company Profile

LeMaitre Vascular, Inc develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature.